Prevalence of and the potential physiopathological mechanisms involved in dyspnea in individuals with class II or III obesity;Prevalência de dispnéia e possíveis mecanismos fisiopatológicos envolvidos em indivíduos com obesidade graus 2 e 3

Jornal Brasileiro de Pneumologia

Volumn 33, Issue 1, 2007, Pages 28-35

  Teixeira, Christiane Aires ^a   Dos Santos, José Ernesto ^a   Silva, Gerusa Alves ^a   De Souza, Elisa Sebba Tosta ^a   Martinez, José Antônio Baddini ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dyspnea epidemiology; Dyspnea physiopathology; Obesity complications; Respiratory function tests

Indexed keywords

EID: 34250368470     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/s1806-37132007000100008     Document Type: Article

References (30)

1. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med. 2003;163(18): 2146-8.
2. Flegal KM, Carrol MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults 1999-2000. JAMA. 2002;288(14):1723-7.
3. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva, Switzerland.: WHO; 2000. (Technical Report Series, 894).
4. Allison DB, Fontaine KR, Manson JE, Stevens J, Vanltallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999;282(16):1530-8.
5. Koenig, SM. Pulmonary complications of obesity. Am J Med Sci. 2001;321(4):249-79.
6. Jubber AS. Respiratory complications of obesity. Int J Clin Pract. 2004;58(6):573-80.
7. Li AM, Chan D, Wong E, Yin J, Nelson EA, Fok TF. The effects of obesity on pulmonary function. Arch Dis Child. 2003;88(4):361-3.
8. Ahmad D, Morgan WK. Obesity and lung function. Thorax. 2001;56(9):740-1
9. Milani RV, Lavie CJ, Mehra MR. Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea? Circulation. 2004;110(4):e27-31.
10. Martinez JAB, Padua AI. Dispnéia: novos conhecimentos sobre um velho problema. In: Terra Filho M, Fernandes ALG, Stirbulov R, editores. Pneumologia. Atualização e reciclagem. São Paulo: Vivali; 2001. vol. 2, p. 1-12.
11. Dyspnea. mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999;159(1):321-40.
12. Curley FJ. Dyspnea. In: Irwin RS, Curley FJ, Grossman RF, editors. Diagnosis and treatment of symptoms of the respiratory tract. New York: Futura; 1997. p. 55-115.
13. Sahebjami H. Dyspnea in obese healthy men. Chest. 1998;114(5):1373-7.
14. Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J et al. The obesity-hypoventilation syndrome revisited. Chest. 2001;120(2):369-76.
15. Patel, SR. Shared genetic risk factors for obstructive sleep apnea and obesity. J Appl Physiol. 2005;99(4):1600-6.
16. Weiss ST, Shore S. Obesity and asthma. Directions for research. Am J Respir Crit Care Med. 2004; 169(8): 963-8.
17. Luder E, Ehrlich RI, Lou WYW, Melnik TA, Kattan M. Body mass index and risk of asthma in adults. Respir Med. 2004;98(1):29-37
18. Gunnbjornsdottir MI, Omenaas E, Gislason T, Norrman E, Olin AC, Jogi R, et al. RHINE Study Group. Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J. 2004;24(1):116-21.
19. Stoller JK, Ferranti R, Feinstein AR. Further specification and evaluation of a new clinical index for dyspnea. Am Rev Am Rev Respir Dis. 1986;134(6):1129-34.
20. Sociedade Brasileira de Pneumologia e Tisiologia. III Consenso Brasileiro no Manejo da Asma 2002. J Pneumol. 2002;28(Supl 1):S3.
21. Pereira CAC, Barreto SP, Simões JG, Pereira FWL, Gerstler JG, Nakatani J, et al. Valores de referência para espirometria em uma amostra da população brasileira adulta. J Bras Pneumol. 1992;18(1):10-22.
22. Neder JA, Andreoni S, Castelo-Filho A, Nery LE. Reference values for lung function tests. I. Static Volumes. Braz J Med Biol Res 1999;32(6):703-17.
23. Neder JA, Andreoni S, Lerario MC, Nery LE. References values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res 1999;32(6):719-27.
24. Miller WF, Scacci R, Gasti LR. Laboratory evaluation of pulmonary function. Philadelphia: Lippincott; 1987.
25. Rasslan Z, Saad Jr R, Stirbulov R, Fabbri RMA, Lima CAC. Avaliação da função pulmonar na obesidade graus 1 e 2. J Bras Pneumol. 2004;30(6):508-14.
26. Rubinstein I, Zamel N, DuBarry L, Hoffstein V. Airflow limitation in morbidly obese, nonsmoking men. Ann Intern Med. 1990;112(11):828-32. Erratum in: Ann Intern Med 1990;113(4):334.
27. Hogg JC, Pare PD, Moreno R. The effects of submucosal edema on airways resistance. Am Rev Respir Dis 1987;135(6 Pt 2):S54-6.
28. Gonen B, O'Donnell P, Post TJ, Quinn TJ, Schulman ES. Very low lipoproteins (VLDL) trigger the release of histamine from human basophils. Biochim Biophys Acta. 1987;917(3):418-24.
29. Canoy D, Luben R, Welch A, Bingham S, Wareham N, Day N, et al. Abdominal obesity and respiratory function in men and women in EPIC-Norfolk Study, United Kingdom. Am J Epidemiol. 2004;159(12):1140-9.
30. Stenius-Aarniala B, Poussa T, Kvarnstrom J, Gronlund EL, Ylikahri M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ. 2000;320(7238):827-32. Erratum in: BMJ. 2000;320(7240):984.